Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	205.22	178.96	170.28	185.31	154.34	98.38
Revenue Growth (YoY)	21.60%	5.10%	-8.11%	20.06%	56.88%	15.65%
Cost of Revenue	79.51	89.16	96.02	75.6	191.64	138.6
Gross Profit	125.71	89.8	74.26	109.71	-37.3	-40.22
Selling, General & Admin	159.25	157.57	172.51	184.13	169.97	110.89
Research & Development	85.87	85.87	101.65	124.07	-	-
Amortization of Goodwill & Intangibles	1.7	1.7	1.7	1.7	1.7	1.7
Operating Expenses	246.82	245.14	275.86	309.9	171.67	112.6
Operating Income	-121.11	-155.34	-201.61	-200.19	-208.97	-152.82
Interest Expense	-11.74	-11.58	-13.8	-4.24	-	-
Interest & Investment Income	6.44	6.33	6.35	4.8	8.9	7.36
EBT Excluding Unusual Items	-126.41	-160.6	-209.06	-199.63	-200.07	-145.45
Merger & Restructuring Charges	-7.21	-7.21	-	-	-	-
Gain (Loss) on Sale of Investments	5.17	8.21	9.18	-0.74	-7.23	-0.77
Asset Writedown	7.21	-	-25.43	-	-	-
Pretax Income	-121.24	-159.6	-225.3	-200.37	-207.3	-146.23
Earnings From Continuing Operations	-121.24	-159.6	-225.3	-200.37	-207.3	-146.23
Minority Interest in Earnings	0.01	0.1	0.05	0.18	0.02	-
Net Income	-121.23	-159.49	-225.25	-200.19	-207.28	-146.23
Net Income to Common	-121.23	-159.49	-225.25	-200.19	-207.28	-146.23
Shares Outstanding (Basic)	149	147	144	143	140	131
Shares Outstanding (Diluted)	149	147	144	143	140	131
Shares Change (YoY)	2.35%	1.88%	1.31%	1.54%	6.96%	89.71%
EPS (Basic)	-0.81	-1.08	-1.56	-1.40	-1.48	-1.11
EPS (Diluted)	-0.81	-1.08	-1.56	-1.40	-1.48	-1.11
Free Cash Flow	-82.81	-98.88	-167.02	-200.29	-254.47	-168.49
Free Cash Flow Per Share	-0.56	-0.67	-1.16	-1.41	-1.81	-1.28
Gross Margin	61.26%	50.18%	43.61%	59.20%	-24.17%	-40.88%
Operating Margin	-59.01%	-86.80%	-118.40%	-108.03%	-135.39%	-155.33%
Profit Margin	-59.07%	-89.12%	-132.28%	-108.03%	-134.30%	-148.63%
Free Cash Flow Margin	-40.35%	-55.25%	-98.09%	-108.09%	-164.87%	-171.26%
EBITDA	-102.84	-136.09	-179.38	-179.27	-195.01	-144.35
EBITDA Margin	-50.11%	-76.05%	-105.34%	-96.74%	-126.35%	-146.72%
D&A For EBITDA	18.27	19.26	22.23	20.92	13.95	8.47
EBIT	-121.11	-155.34	-201.61	-200.19	-208.97	-152.82
EBIT Margin	-59.01%	-86.80%	-118.40%	-108.03%	-135.39%	-155.33%
Advertising Expenses	-	6.1	8.6	13.7	-	14.5

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q